Mark R Miglarese

age ~59

from Phoenix, AZ

Get Report
Also known as:
  • Mark Robert Miglarese
  • Mark B Miglarese
  • Mary S Shafer
  • Mary Wren
  • Mark E
Phone and address:
1620 E Silverwood Dr, Phoenix, AZ 85048
8607677880
Related to:
Connected to:

Mark Miglarese Phones & Addresses

  • 1620 E Silverwood Dr, Phoenix, AZ 85048 • 8607677880
  • 15 Rosewood Ln, Ivoryton, CT 06442 • 8607677880
  • Brighton, CO
  • Raleigh, NC
  • Pittsboro, NC
  • Farmingdale, NY
  • New York, NY
  • Sparta, NJ
  • Superior, CO
  • Boulder, CO
  • Superior, CO
  • 15 Rosewood Ln, Ivoryton, CT 06442

Work

  • Company:
    Onconex consulting llc
    Jan 2015
  • Position:
    Owner

Education

  • School / High School:
    Yale University School of Medicine
    1995
  • Specialities:
    Doctoral in Research Department

Skills

Oncology • Drug Discovery • Cancer • Drug Development • Biotechnology • Clinical Development • Translational Medicine • Immunology • Pharmaceutical Industry • Clinical Research • Biomarkers • Translational Research • Molecular Biology • Pharmacology • Biomarker Discovery • Biochemistry • Clinical Trials • Cell Biology • Assay Development • Biopharmaceuticals • Protein Chemistry • Cro • Cell • Genomics • In Vitro • Inflammation

Industries

Biotechnology

Resumes

Mark Miglarese Photo 1

Vice President - Research, Development And Clinical Science

view source
Location:
Phoenix, AZ
Industry:
Biotechnology
Work:
Caris Life Sciences
Vice President - Research, Development and Clinical Science
Onconex Consulting Jan 2015 - Aug 2015
Owner
Caris Life Sciences Jan 2015 - Aug 2015
Vice President, Research and Development
Cielo Therapeutics Feb 2015 - Jul 2015
Interim Chief Scientific Officer
Genecentric Diagnostics May 2013 - Aug 2014
Chief Scientific Officer
Education:
University of Virginia 1988 - 1995
Doctorates, Doctor of Philosophy, Microbiology Virginia Tech 1984 - 1988
Bachelors, Bachelor of Science, Biology Sparta High School
Skills:
Oncology
Drug Discovery
Cancer
Drug Development
Biotechnology
Clinical Development
Translational Medicine
Immunology
Pharmaceutical Industry
Clinical Research
Biomarkers
Translational Research
Molecular Biology
Pharmacology
Biomarker Discovery
Biochemistry
Clinical Trials
Cell Biology
Assay Development
Biopharmaceuticals
Protein Chemistry
Cro
Cell
Genomics
In Vitro
Inflammation
Mark Miglarese Photo 2

Mark Miglarese Brighton, CO

view source
Work:
OncoNex Consulting LLC

Jan 2015 to 2000
Owner GeneCentric Diagnostics
Durham, NC
May 2013 to Jul 2014
Chief Scientific Officer Oncology Translational and Clinical Science
Farmingdale, NY
2012 to 2013
Vice President Oncology Translational and Clinical Science
Farmingdale, NY
2011 to 2012
Vice President Oncology Translational and Clinical Science

2009 to 2011
Vice President Oncology Translational and Clinical Science

2007 to 2009
Senior Director Translational Research, Array BioPharma, Inc
Boulder, CO
2005 to 2007
Assistant. Director Department of Cancer Biology, Bayer HealthCare Pharmaceuticals
West Haven, CT
2004 to 2005
Section Head Bayer

2002 to 2004
Segment Representative and Principal Research Scientist I Bayer

1997 to 2002
Research Scientist, Senior Research Scientist I and II
Education:
Yale University School of Medicine
1995 to 1997
Doctoral in Research Department University of Virginia
Charlottesville, VA
1988 to 1995
Ph.D. in Cancer Center Virginia Polytechnic Institute and State University
Blacksburg, VA
1984 to 1988
B.S. in Biology

Us Patents

  • Therapeutic Oligonucleotides

    view source
  • US Patent:
    20220356203, Nov 10, 2022
  • Filed:
    Feb 3, 2021
  • Appl. No.:
    17/166071
  • Inventors:
    - Irving TX, US
    Günter Mayer - Bonn, DE
    Mark Miglarese - Phoenix AZ, US
    David Spetzler - Paradise Valley AZ, US
  • International Classification:
    C07H 19/173
    A61K 47/69
    A61P 37/00
    A61P 25/28
    A61P 31/00
    A61P 9/00
    A61P 35/02
    A61P 29/00
    A61K 9/00
    C07H 19/09
    C07H 19/19
    C07H 21/00
    C12N 15/10
    C12N 15/115
    C12Q 1/6886
    G06T 7/00
    G01N 33/574
    G01N 33/53
    G01N 33/68
  • Abstract:
    Methods and compositions are provided for oligonucleotides that bind targets of interest. The targets include cells and microvesicles, such as those derived from various diseases. The oligonucleotides can be used for diagnostic and therapeutic purposes. The target of the oligonucleotides can be a target such as PARP1, HIST1H1B, HIST1H1D, NCL, FBL, SFPQ, RPL12, ACTB, HIST1H4A, SSBP1, NONO, H2AFJ, and DDX21, or a complex, subunit or fragment thereof.

  • Oligonucleotide Probes And Uses Thereof

    view source
  • US Patent:
    20220290124, Sep 15, 2022
  • Filed:
    Feb 25, 2022
  • Appl. No.:
    17/680983
  • Inventors:
    - Irving TX, US
    Tassilo Hornung - Phoenix AZ, US
    Mark Miglarese - Phoenix AZ, US
    David Spetzler - Paradise Valley AZ, US
  • International Classification:
    C12N 15/10
    C12N 15/115
    C40B 20/02
    C40B 20/04
    C40B 40/08
  • Abstract:
    Methods and compositions are provided to identify oligonucleotides that bind targets of interest. The targets include tissues, cells, circulating biomarkers such as microvesicles, including those derived from various diseases. The oligonucleotides can be used in diagnostic and therapeutic applications.

  • Oligonucleotide Probes And Uses Thereof

    view source
  • US Patent:
    20210062191, Mar 4, 2021
  • Filed:
    Jun 10, 2020
  • Appl. No.:
    16/897976
  • Inventors:
    - Irving TX, US
    Tassilo Hornung - Phoenix AZ, US
    Heather O'Neill - Mesa AZ, US
    Mark Miglarese - Phoenix AZ, US
    David Spetzler - Paradise Valley AZ, US
  • International Classification:
    C12N 15/115
    C12N 15/10
    C12Q 1/6883
    C12Q 1/6886
  • Abstract:
    Methods and compositions are provided to identify oligonucleotides that bind targets of interest. The targets include tissues, cells, circulating biomarkers such as microvesicles, including those derived from various diseases. The oligonucleotides can be used in diagnostic and therapeutic applications.

  • Oligonucleotide Probes And Uses Thereof

    view source
  • US Patent:
    20200376022, Dec 3, 2020
  • Filed:
    Mar 27, 2018
  • Appl. No.:
    16/497024
  • Inventors:
    - Irving TX, US
    Xianghua Liu - Chandler AZ, US
    Mark Miglarese - Phoenix AZ, US
    David Spetzler - Paradise Valley AZ, US
  • Assignee:
    Caris Science, Inc. - Irving TX
  • International Classification:
    A61K 31/7125
    C12Q 1/6811
    C12Q 1/6886
  • Abstract:
    Methods and compositions are provided for oligonucleotides that bind targets of interest. The targets include circulating biomarkers such as micro vesicles, including those derived from various diseases.

  • Therapeutic Oligonucleotides

    view source
  • US Patent:
    20200277606, Sep 3, 2020
  • Filed:
    Feb 6, 2020
  • Appl. No.:
    16/783412
  • Inventors:
    - Irving TX, US
    Mark Miglarese - Phoenix AZ, US
    David Spetzler - Paradise Valley AZ, US
  • International Classification:
    C12N 15/115
    A61K 31/711
    A61K 47/68
    G01N 33/53
  • Abstract:
    Methods and compositions are provided for oligonucleotides that bind targets of interest. The targets include cells and microvesicles, such as those derived from various diseases. The oligonucleotides can be used for diagnostic and therapeutic purposes. The target of the oligonucleotides can be a therapeutic target such as Complement Component 1, Q Subcomponent (C1q) or a subunit thereof.

  • Oligonucleotide Probes And Uses Thereof

    view source
  • US Patent:
    20200270610, Aug 27, 2020
  • Filed:
    Nov 25, 2019
  • Appl. No.:
    16/694851
  • Inventors:
    - Irving TX, US
    Adam STARK - Surprise AZ, US
    Nianqing XIAO - Rockville MD, US
    Zhenyu ZHONG - Peoria AZ, US
    Mark MIGLARESE - Phoenix AZ, US
    David SPETZLER - Paradise Valley AZ, US
  • Assignee:
    Caris Science, Inc. - Irving TX
  • International Classification:
    C12N 15/115
    C12Q 1/6886
    C40B 20/08
    G01N 33/50
  • Abstract:
    Methods and compositions are provided for oligonucleotide probes and oligonucleotide probe libraries that recognize targets of interest. The targets include circulating biomarkers such as microvesicles, including those derived from various diseases.

  • Oligonucleotide Probes And Uses Thereof

    view source
  • US Patent:
    20200032265, Jan 30, 2020
  • Filed:
    Sep 27, 2017
  • Appl. No.:
    16/337367
  • Inventors:
    - Irving TX, US
    Heather O'Neill - Mesa AZ, US
    Mark Miglarese - Phoenix AZ, US
    David Spetzler - Paradise Valley AZ, US
  • International Classification:
    C12N 15/115
    C12Q 1/70
    A61K 31/7088
  • Abstract:
    Methods and compositions are provided for oligonucleotides and libraries of oligonucleotides that bind targets of interest. The targets include cellular biomarkers of viral infection. The viral infection may be that of human immunodeficiency virus-1.

  • Oligonucleotide Probes And Uses Thereof

    view source
  • US Patent:
    20190367903, Dec 5, 2019
  • Filed:
    May 25, 2017
  • Appl. No.:
    16/304389
  • Inventors:
    - Irving TX, US
    Tassilo HORNUNG - Phoenix AZ, US
    Mark MIGLARESE - Phoenix AZ, US
    David SPETZLER - Paradise Valley AZ, US
  • International Classification:
    C12N 15/10
    C40B 20/02
    C12N 15/115
    C40B 20/04
    C40B 40/08
  • Abstract:
    Methods and compositions are provided to identify oligonucleotides that bind targets of interest. The targets include tissues, cells, circulating biomarkers such as microvesicles, including those derived from various diseases. The oligonucleotides can be used in diagnostic and therapeutic applications.

Myspace

Mark Miglarese Photo 3

Migs (Mark Miglarese) My...

view source
MySpace profile for Mark Miglarese. Find friends, share photos, keep in touch with classmates, and meet new people on MySpace.

Youtube

EO Day Joint Keynote: Anne MIGLARESE: "Innova...

EO Day Joint Keynote: Anne MIGLARESE: "Innovation ...

This is a live recording of Anne Hale Miglarese's Keynote of the GI_Fo...

  • Duration:
    53m 19s

Steven "lil Smokey" Granzella - What TRT Can ...

Steven "lil Smokey" Granzella - What TRT Can do Af...

In this Podcast Episode, Steven Granzella aka lil Smokey, Mark Bell, N...

  • Duration:
    1h 47m 24s

What to eat to lose weight & my realistic dai...

What to eat to lose weight & my realistic daily di...

Hihihihihi! VIDEO MENTIONED:...

  • Duration:
    13m 5s

Men's Soccer: vs. Limestone College

Men's Soccer: vs. Limestone College

Head coach John Miglarese's thoughts on King's 1-0 defeat to Limestone...

  • Duration:
    1m 33s

Mission Impossible : Malta - Forced To Recycle

Mission Impossible : Malta - Forced To Recycle

When an easy mission becomes the Mission Impossible even for Tom Cruis...

  • Duration:
    12m 31s

Microbial management and regenerative agricul...

Microbial management and regenerative agriculture ...

What is the role of regenerative agriculture in low rainfall cropping ...

  • Duration:
    18m 29s
Get Report for Mark R Miglarese from Phoenix, AZ, age ~59
Control profile